Parra, Mario A.Orellana, PaulinaLeón, TomasVictoria, Cabello G.Henriquez, FernandoGomez, RodrigoAvalos, ConstanzaDamian, AndresSlachevsky Chonchol, AndreaIbañez, AgustinZetterberg, HenrikTijms, Betty M.Yokoyama, Jennifer S.Piña-Escudero, Stefanie D.Cochran, NicholasMatallana, Diana L.Acosta, DaisyAllegri, RicardoArias-Suáres, Bianca P.Barra, BernardoBehrens, María IsabelBrucki, Sonia M.D.Busatto, GeraldoCaramelli, PauloCastro-Suarez, SheilaContreras, ValeriaCustodio, NiltonDansilio, SergioDe la Cruz-Puebla, MyriamCruz de Souza, LeonadoDíaz, Monica M.Duque, LissetteFarias, Gonzalo A.Ferreira, Sergio T.Magrath Guimet, NahuelKmaid, AnaLira, DavidLopera, FranciscoMar Meza, BeatrizMiotto, Eliane C.2024-06-032024-06-032023Parra MA, Orellana P, Leon T, Victoria CG, Henriquez F, Gomez R, Avalos C, Damian A, Slachevsky A, Ibañez A, Zetterberg H, Tijms BM, Yokoyama JS, Piña-Escudero SD, Cochran JN, Matallana DL, Acosta D, Allegri R, Arias-Suárez BP, Barra B, Behrens MI, Brucki SMD, Busatto G, Caramelli P, Castro-Suarez S, Contreras V, Custodio N, Dansilio S, la Cruz-Puebla M, de Souza LC, Diaz MM, Duque L, Farías GA, Ferreira ST, Guimet NM, Kmaid A, Lira D, Lopera F, Meza BM, Miotto EC, Nitrini R, Nuñez A, O'Neill S, Ochoa J, Pintado-Caipa M, Resende EPF, Risacher S, Rojas LA, Sabaj V, Schilling L, Sellek AF, Sosa A, Takada LT, Teixeira AL, Unaucho-Pilalumbo M, Duran-Aniotz C. Biomarkers for dementia in Latin American countries: Gaps and opportunities. Alzheimers Dement. 2023 Feb;19(2):721-735. doi: 10.1002/alz.12757.https://hdl.handle.net/11447/8998Ricardo Nitrini, Alberto Nuñez, Santiago O'Neill, John Ochoa, Maritza Pintado-Caipa, Elisa de Paula França Resende, Shannon Risacher, Luz Angela Rojas, Valentina Sabaj, Lucas Schilling, Allis F Sellek, Ana Sosa, Leonel T Takada, Antonio L Teixeira, Martha Unaucho-Pilalumbo, Claudia Duran-AniotzLimited knowledge on dementia biomarkers in Latin American and Caribbean (LAC)countries remains a serious barrier. Here, we reported a survey to explore the ongo-ing work, needs, interests, potential barriers, and opportunities for future studiesrelated to biomarkers. The results show that neuroimaging is the most used biomarker(73%), followed by genetic studies (40%), peripheral fluids biomarkers (31%), and cere-brospinal fluid biomarkers (29%). Regarding barriers in LAC, lack of funding appears toundermine the implementation of biomarkers in clinical or research settings, followedby insufficient infrastructure and training. The survey revealed that despite the abovebarriers, the region holds a great potential to advance dementia biomarkers research.Considering the unique contributions that LAC could make to this growing field,we highlight the urgent need to expand biomarker research. These insights allowedus to propose an action plan that addresses the recommendations for a biomarkerframework recently proposed by regional experts.15 p.enAtribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)DementiaDiagnosisHumansLatin AmericaArticlehttps://doi.org/ 10.1002/alz.12757